Navigation Links
AMDL Presentation of China Success Story from Rodman & Renshaw Annual Healthcare Conference Available at WallStreetReporter.com
Date:11/23/2007

TUSTIN, Calif., Nov. 23 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL - News), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi and Jilin, China, through its wholly owned subsidiary Jade Pharmaceutical Inc. (JPI), is an international biopharma company that engages in the development, manufacture and marketing of proprietary pharmaceutical and diagnostic products. The Company announced today that the recent presentation by its CEO, Gary Dreher, at the prestigious 9th Annual Healthcare Conference sponsored by the full-service investment bank, Rodman & Renshaw, and its life science division, Acumen BioFin,(TM) is now available at WallStreetRepoter.com.

The link to listen to the presentation is at http://www.wallstreetreporter.com/page.php?page=view_videos&id=134

Mr. Dreher noted that "AMDL recently announced that it had sales of approximately $5.8 million for the third quarter of 2007 compared to $2.3 million for the second quarter of 2007 with $0.05 per share in earnings. AMDL's introduction of new products and increased distribution channels caused the upturn in revenues and profits. This marked AMDL's first quarter with positive cash flow and net earnings. These superior results indicate that we anticipate that our Chinese subsidiaries will continue to experience strong sales and gross profit growth that will greatly improve AMDL's combined operating results."

About JPI: Jade Pharmaceutical has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its subsidiary, Jade currently manufactures large volume injectable fluids, tablets and other related products, holding licenses for 133 products. It also manufactures 107 generic, over the counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

About AMDL: More information about AMDL and its products can be obtained at http://www.amdl.com .

Contact: AMDL, Inc.

Paul Knopick

AMDL Investor Relations

Direct Line: 949.707.5365

Voice Mail: 714.505.4460


'/>"/>
SOURCE AMDL, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Strategic Diagnostics Updates Roth Conference Presentation Time
2. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
3. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
4. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
5. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
9. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
10. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
11. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... ... May 17, 2017 , ... G-CON Manufacturing, ... Chief Executive Officer, Maik Jornitz, was recognized as a Top 10 Industry Influencer ... 100 individuals “involved in bettering the pharma industry and bringing life-changing medicines to ...
(Date:5/16/2017)... Arlington, VA (PRWEB) , ... May 16, 2017 ... ... U.S. Patent and Trademark Office (USPTO) for a wireless electrocardiogram (ECG or EKG) ... monitoring devices to be integrated into clothing, or secured directly onto the skin, ...
(Date:5/15/2017)... ... , ... Tunnell Consulting announced that Julia O’Neill, principal and statistician, ... in Process Validation,” at the Process Validation Summit 2017, May 18 and 19, ... the pharmaceutical and biotech industries to explore processes, strategies and new approaches to ensuring ...
(Date:5/12/2017)... , May 12, 2017 GreenMark Biomedical Inc. ... at the 36th annual Michigan Growth Capital Symposium (MGCS) ... Delaware corporation with facilities in ... investors in attendance, including more than 100 top venture ... to society through biobased targeting technologies. GreenMark ...
Breaking Biology Technology:
(Date:3/30/2017)... -- Trends, opportunities and forecast in this market to ... AFIS, iris recognition, facial recognition, hand geometry, vein recognition, ... industry (government and law enforcement, commercial and retail, health ... and by region ( North America , ... , and the Rest of the World) ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/24/2017)... 2017 The Controller General of Immigration from Maldives ... Algeen have received the prestigious international IAIR Award for the most ... Reading ... Maldives ... Abdulla Algeen (small picture on the right) have received the IAIR award ...
Breaking Biology News(10 mins):